EMA
withdrawal
· 2012-11-23
EMA Refused: Elelyso (taliglucerase alfa) — Pfizer Ltd.
Summary
The EMA refused the marketing authorization for Elelyso (taliglucerase alfa) by Pfizer Ltd., in the Gaucher disease indication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Refused. Therapeutic area: Gaucher Disease. MAH: Pfizer Ltd.. Decision date: 29/10/2012. Orphan medicine